C

Compass Oncology | Vancouver, WA

Research site
(Unclaimed)
Location
1498 Tech Center Place, Suite 240, Vancouver, Washington, United States of America
Site insights

Top conditions

Leukemia (2 trials)

Non-Small-Cell Lung Carcinoma (2 trials)

Cancer (2 trials)

Lung Cancer (1 trial)

BCR-ABL Positive Chronic Myelogenous Leukemia (1 trial)

Top treatments

MSB0011359C
Demcizumab
Platinum
M7824
Carboplatin
Osimertinib
NUC-3373
Lazertinib
Amivantamab
Nilotinib

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

3 of 7
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy Compared With Platinum-Based Chemotherapy in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non- Small Cell Lung Cancer After Osimertinib Failure (MARIPOSA-2)

The purpose of this study is to assess the efficacy of adding lazertinib to amivantamab, carboplatin, and pemetrexed (LACP/ACP-L dosing strategies) a...

Active, not recruiting
Carcinoma, Non-Small-Cell Lung
Drug: Pemetrexed
Drug: Carboplatin

A Randomized, Double-blind, Multi-center, Phase III Clinical Study of Ivonescimab (SMT112 or AK112) or Placebo Plus Pemetrexed and Carboplatin in Pat...

Enrolling
Non-Squamous Non-small Cell Lung Cancer
Drug: Placebo Injection
Drug: Ivonescimab (SMT112 or AK112) Injection

A clinical research study to find out if it is safe to stop the drug nilotinib (Tasigna) in chronic myeloid leukemia (CML) patients. Patients who sta...

Active, not recruiting
Chronic Myeloid Leukemia
Drug: nilotinib

Trial sponsors

Janssen logo

Janssen (1 trial)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems